At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases.
Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team.
If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.
Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team.
If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.
Location: Taiwan, Taipei
Employees: 51-200
Total raised: $23M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | YFY Biotec... | tgbfund.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.06.2020 | - | $23M | - |
Mentions in press and media 14
| Date | Title | Description |
| 26.08.2021 | Taiwan Liposome : 2021 First EGM Minutes | Taiwan Liposome Company, Ltd. Meeting Minutes for the First Extraordinary General Meeting of 2021 (the "Meeting") (Translation) Time: August 20, 2021 (Friday) at 9:00 a.m. Venue: 7F, No. 3, Yuanqu St., Nangang Dist., Taipei City (... |
| 12.08.2021 | Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update | TLC Reports Second Quarter 2021 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan - August 12, 2021 - TLC, a clinical-stagespecialty pharmaceutical company developing novel nanomedicines to target are... |
| 12.08.2021 | TLC Reports Second Quarter 2021 Financial Results and Provides Business Update | SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced financial results... |
| 25.05.2021 | TAIWAN LIPOSOME COMPANY, LTD. Taiwan Liposome : TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India | TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan - May 25, 2021 - TLC (Nasdaq: TLC, TWO: 4152), a clinical-stagespecialty pharmaceutical company developing novel ... |
| 03.05.2021 | TAIWAN LIPOSOME COMPANY, LTD. Taiwan Liposome : TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years Running | TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years Running Praised as benchmark for small and medium-sized enterprises SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan - May 3, 2021 - TLC(Nasdaq: TLC, TWO: 4152), a clinical-... |
| 22.02.2021 | TAIWAN LIPOSOME COMPANY, LTD. Taiwan Liposome : 2020 Annual Unconsolidated Financial Statements | TAIWAN LIPOSOME COMPANY, LTD. PARENT COMPANY ONLY FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS' REPORT YEARS ENDED DECEMBER 31, 2020 AND 2019 ~1~ TAIWAN LIPOSOME COMPANY, LTD. PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2020 AND 2019 (... |
| 22.02.2021 | Taiwan Liposome : 2020 Annual Unconsolidated Financial Statements | TAIWAN LIPOSOME COMPANY, LTD. PARENT COMPANY ONLY FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS' REPORT YEARS ENDED DECEMBER 31, 2020 AND 2019 ~1~ TAIWAN LIPOSOME COMPANY, LTD. PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2020 AND 2019 (... |
| 22.02.2021 | Taiwan Liposome : 2020 Annual Consolidated Financial Statements | TAIWAN LIPOSOME COMPANY, LTD. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS' REPORT YEARS ENDED DECEMBER 31, 2020 AND 2019 ~1~ TAIWAN LIPOSOME COMPANY, LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS DECEMBER... |
| 22.02.2021 | TAIWAN LIPOSOME COMPANY, LTD. Taiwan Liposome : 2020 Annual Consolidated Financial Statements | TAIWAN LIPOSOME COMPANY, LTD. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS' REPORT YEARS ENDED DECEMBER 31, 2020 AND 2019 ~1~ TAIWAN LIPOSOME COMPANY, LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS DECEMBER... |
| 03.11.2020 | TAIWAN LIPOSOME COMPANY, LTD. Taiwan Liposome : 2020 Q3 Consolidated Financial Statements | TAIWAN LIPOSOME COMPANY, LTD. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AND REVIEW REPORT OF INDEPENDENT ACCOUNTANTS NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019 For the convenience of readers and for information purpose only, the... |
Show more